SCHEMBL7128804

SCHEMBL7128804

O=C(Nc1ccc(NS(=O)(=O)c2ccccc2)cc1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.74
KMT2A Q03164 6/20 0.74
CYP3A4 P08684 3/20 0.74
TP53 P04637 2/20 0.74
MAPK1 P28482 2/20 0.74
PPARG P37231 2/20 0.74
SMN1; SMN2 Q16637 2/20 0.74
LMNA P02545 1/20 0.74
CYP1A2 P05177 1/20 0.74
CYP2D6 P10635 1/20 0.74
MAPT P10636 1/20 0.74
CYP2C9 P11712 1/20 0.74
PKM P14618 1/20 0.74
TSHR P16473 1/20 0.74
NFKB1 P19838 1/20 0.74
CYP2C19 P33261 1/20 0.74
THPO P40225 1/20 0.74
MTOR P42345 1/20 0.74
RORC P51449 1/20 0.74
PMP22 Q01453 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7120767 0.97 MEN1 (0.69) MEN1KMT2ACYP3A4TP53MAPK1
SCHEMBL7132438 0.91 RORC (0.71) MEN1KMT2ACYP3A4TP53MAPK1
SCHEMBL7132305 0.90 KMT2A (0.62) MEN1KMT2ACYP3A4TP53MAPK1
SCHEMBL7118614 0.90 KMT2A (0.62) MEN1KMT2ACYP3A4TP53MAPK1
SCHEMBL7120763 0.88 RORC (0.63) MEN1KMT2ACYP3A4TP53MAPK1
SCHEMBL7129479 0.87 KMT2A (0.58) MEN1KMT2ACYP3A4TP53MAPK1
SCHEMBL7118637 0.87 KMT2A (0.58) MEN1KMT2ACYP3A4TP53MAPK1
SCHEMBL7129852 0.86 TP53 (0.69) MEN1KMT2ACYP3A4TP53MAPK1
SCHEMBL27180767 0.86 MEN1 (0.77) MEN1KMT2ACYP3A4TP53MAPK1
SCHEMBL29369092 0.86 RORC (1.00) MEN1KMT2ACYP3A4TP53MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD MEN1 4865/4885KMT2A 3291/4885CYP3A4 1516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.